Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Red candles

<< Previous

Bullboard Posts

Next >>

Comment by themagicboxon Aug 19, 2021 12:36pm

108 Views

Post# 33730867

RE:RE:RE:RE:RE:RE:RE:Red candles

omg you're dumber than I thought. The warrants were given in addition to any common shares purchased during the bought deal. So if you sell the common shares you have the warrants for free.

You really dont know anything. Thats why you're spreading FUD. Keeping saying youre invested in this company and want it to succeed. "yOlO 25K sHaReS" haha!!

Rarbar99 wrote: "Rising this risk free" you mean other than losing 70% of your asset value in a matter of days? There's levels to the investing game and frankly, you're an amateur.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market